| scholarly article | Q13442814 |
| P50 | author | Zhongqiu Lu | Q57058454 |
| P2093 | author name string | Xiaoli Wu | |
| Fujun Yu | |||
| Bicheng Chen | |||
| Jianjian Zheng | |||
| Peihong Dong | |||
| P2860 | cites work | Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro | Q21284189 |
| EUKARYOTIC CYTOSINE METHYLTRANSFERASES | Q22255656 | ||
| The epithelial-mesenchymal transition: new insights in signaling, development, and disease | Q24683758 | ||
| Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis | Q28566912 | ||
| CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma | Q31040425 | ||
| Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis | Q33771703 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| Role of PTCH1 gene methylation in gastric carcinogenesis | Q33844086 | ||
| Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction | Q34023700 | ||
| Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. | Q34299086 | ||
| Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma | Q35192302 | ||
| Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions | Q35768982 | ||
| Cytokines and STATs in Liver Fibrosis | Q35867085 | ||
| The key to development: interpreting the histone code? | Q36083253 | ||
| Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. | Q36308206 | ||
| Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling | Q36456025 | ||
| Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans | Q36890842 | ||
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. | Q37262433 | ||
| The potential of microRNAs in liver fibrosis | Q38033924 | ||
| MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. | Q38881975 | ||
| Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT. | Q38948202 | ||
| Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway | Q38956770 | ||
| Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation | Q39062251 | ||
| DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis | Q39208219 | ||
| Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells | Q40023334 | ||
| Role for hedgehog signaling in hepatic stellate cell activation and viability | Q40371810 | ||
| microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis | Q41808402 | ||
| HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells | Q41862856 | ||
| Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells | Q41980364 | ||
| Knockdown of N-acetylglucosaminyl transferase V ameliorates hepatotoxin-induced liver fibrosis in mice | Q42710532 | ||
| Salvianolic acid B inhibited PPARγ expression and attenuated weight gain in mice with high-fat diet-induced obesity | Q42799487 | ||
| Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis | Q46181877 | ||
| In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells | Q46824760 | ||
| Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. | Q50486496 | ||
| Sedum sarmentosum Bunge extract exerts renal anti-fibrotic effects in vivo and in vitro. | Q54212480 | ||
| OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. | Q54391067 | ||
| Suppression of hepatic stellate cell activation by microRNA-29b. | Q54571179 | ||
| P433 | issue | 11 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 2617-2632 | |
| P577 | publication date | 2015-08-10 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation | |
| P478 | volume | 19 |
| Q49540955 | Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats |
| Q93148554 | Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro |
| Q92870844 | Effect of Toll-Like Receptor 4/Myeloid Differentiation Factor 88 Inhibition by Salvianolic Acid B on Neuropathic Pain After Spinal Cord Injury in Mice |
| Q98244047 | Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation |
| Q64984213 | Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition. |
| Q26752932 | Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis |
| Q49940586 | Involvement of epithelial-mesenchymal transition in liver fibrosis |
| Q57035120 | LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212 |
| Q37665189 | Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152. |
| Q47899728 | Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer |
| Q47972727 | MicroRNA-132 upregulation promotes matrix degradation in intervertebral disc degeneration |
| Q26740198 | MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling |
| Q39377055 | Novel Anti-fibrotic Therapies |
| Q64259452 | Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis |
| Q64055454 | Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway |
| Q37607444 | Salvia-Nelumbinis Naturalis Formula Improved Inflammation in LPS Stressed Macrophages via Upregulating MicroRNA-152. |
| Q28554444 | Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice |
| Q64229967 | Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer |
| Q41334657 | Salvianolic acid B protects hepatocytes from H2O2 injury by stabilizing the lysosomal membrane |
| Q40364000 | Serum lincRNA-p21 as a potential biomarker of liver fibrosis in chronic hepatitis B patients |
| Q38719605 | Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression. |
| Q91968727 | The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients |
| Q36545987 | miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1. |
| Q91971092 | miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN |
Search more.